verapamil has been researched along with Central Hypothyroidism in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim of this study was to investigate antiarrhythmic and toxic effects of verapamil in mice and rats with thyrotoxicosis and hypothyroidism." | 7.74 | [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. ( Afanas'eva, EIu; Arzamastsev, EV; Sokhanenkov, MIu; Sokhanenkova, AE, 2008) |
| "In some patients with severe hypothyroidism, thyroxine replacement therapy precipitates or aggravates angina pectoris, whereas in other patients angina pectoris is ameliorated or even cured." | 7.68 | Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism. ( Bernstein, R; Haug, E; Hertzenberg, L; Kjørstad, KE; Midtbø, K; Müller, C; Nakken, KF, 1991) |
| "Aim of this study was to investigate antiarrhythmic and toxic effects of verapamil in mice and rats with thyrotoxicosis and hypothyroidism." | 3.74 | [Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats]. ( Afanas'eva, EIu; Arzamastsev, EV; Sokhanenkov, MIu; Sokhanenkova, AE, 2008) |
| "In some patients with severe hypothyroidism, thyroxine replacement therapy precipitates or aggravates angina pectoris, whereas in other patients angina pectoris is ameliorated or even cured." | 3.68 | Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism. ( Bernstein, R; Haug, E; Hertzenberg, L; Kjørstad, KE; Midtbø, K; Müller, C; Nakken, KF, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sokhanenkova, AE | 1 |
| Sokhanenkov, MIu | 1 |
| Afanas'eva, EIu | 1 |
| Arzamastsev, EV | 1 |
| Andersson, DE | 1 |
| Röjmark, S | 1 |
| Veksler, VI | 1 |
| Levitskaya, EL | 1 |
| Khatkevich, AN | 1 |
| Orekhova, IV | 1 |
| Khuchua, ZA | 1 |
| Kapelko, VI | 1 |
| Doughty, JC | 1 |
| Donald, AK | 1 |
| Keogh, G | 1 |
| Cooke, TG | 1 |
| Seppet, EK | 1 |
| Kolar, F | 1 |
| Dixon, IM | 1 |
| Hata, T | 1 |
| Dhalla, NS | 1 |
| Bernstein, R | 1 |
| Müller, C | 1 |
| Midtbø, K | 1 |
| Haug, E | 1 |
| Nakken, KF | 1 |
| Hertzenberg, L | 1 |
| Kjørstad, KE | 1 |
| Hagino, Y | 1 |
| Nomura, H | 1 |
| Nomura, T | 1 |
| Maekawa, H | 1 |
| Izuhara, K | 1 |
| Tachibana, M | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Minnielli, S | 1 |
| D'Amico, C | 1 |
| Di Pietro, ML | 1 |
| Albini, C | 1 |
| Passeri, M | 1 |
| Liberale, I | 1 |
| Menini, E | 1 |
| Barbarino, A | 1 |
8 other studies available for verapamil and Central Hypothyroidism
| Article | Year |
|---|---|
[Characteristics of pharmacological and toxic effects of verapamil during cardiac arrhythmia in thyrotoxic and hypothyroid rats].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relatio | 2008 |
Effect of verapamil on blood glucose and serum insulin in patients with hyper- and hypothyroidism.
Topics: Adult; Aged; Blood Glucose; Female; Humans; Hyperthyroidism; Hypothyroidism; Insulin; Male; Middle A | 1980 |
Myocardial adaptation to long-term action of substances associated with decreased intensity of cardiac function.
Topics: Adaptation, Physiological; Adenosine Triphosphatases; Animals; Body Weight; Calcium; Heart; Hypothyr | 1994 |
Stercoral perforation with verapamil.
Topics: Aged; Chronic Disease; Constipation; Female; Humans; Hypothyroidism; Intestinal Perforation; Sigmoid | 1994 |
Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone.
Topics: Animals; Calcium Channels; Calcium-Binding Proteins; Heart; Hyperthyroidism; Hypothyroidism; In Vitr | 1993 |
Cardiac left ventricular function before and during early thyroxine treatment in severe hypothyroidism.
Topics: Adult; Aged; Exercise Test; Female; Gated Blood-Pool Imaging; Humans; Hypothyroidism; Male; Middle A | 1991 |
The role of calcium ion in methoxamine-induced amylase release from parotid glands of euthyroid and hypothyroid rats.
Topics: Adrenergic alpha-Agonists; Amylases; Animals; Calcium; Calmodulin; Hypothyroidism; Male; Methoxamine | 1985 |
Calcium antagonists and hormone release. V. Effects of a calcium-antagonist (verapamil) on pituitary hormone release in hypersecretory states.
Topics: Acromegaly; Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypogonadism; Hypothyroidism; Male; | 1987 |